LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
17.08
-1.06 (-5.84%)
At close: Dec 15, 2025, 4:00 PM EST
17.95
+0.87 (5.09%)
After-hours: Dec 15, 2025, 7:59 PM EST
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $534.43 million as of December 15, 2025. Its market cap has decreased by -46.39% in one year.
Market Cap
534.43M
Enterprise Value
333.21M
1-Year Change
-46.39%
Ranking
Category
Stock Price
$17.08
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has increased from $413.64M to $534.43M, an increase of 29.20%. That is a compound annual growth rate of 16.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 567.60M | -28.51% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |